← FDA Drug Approvals (Drugs@FDA)

APREMILAST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2021-06-30

Drug application

FDA Application #

ANDA211782

Application type

Abbreviated New Drug Application (Generic)

Brand name

APREMILAST

Generic name

Apremilast

Active ingredients

APREMILAST

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AMNEAL

First approval

2021-06-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown